(Q63915205)

English

The novel adjuvant CoVaccineHT™ increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro

article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

infectious disease

1 reference

based on heuristic

inferred from title

immunologic adjuvant

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

R. Bodewes

R Bodewes

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

7

object named as

A D M E Osterhaus

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Guus Rimmelzwaan

8

object named as

G F Rimmelzwaan

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

M M Geelhoed-Mieras

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

J G M Heldens

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

J Glover

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

B N Lambrecht

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

R A M Fouchier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

17 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

6833-6839

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A pandemic warning?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Pandemic H5N1 influenza vaccine development: an update.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Ready for avian flu?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Vaccines against influenza A (H5N1): evidence of progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Effects of GnRH immunization in sexually mature pony stallions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Innate-immunity cytokines induced by very small size proteoliposomes, a Neisseria-derived immunological adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

IL-10: the master regulator of immunity to infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.015

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.09.015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19772942%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q63915205&oldid=1790136371"